Yuyu Pharma, Inc. (000225-KS) Stock Split, History Data
Working capital analysis
In terms of working capital, Yuyu Pharma, Inc. maintains a healthy position.
The total current assets of the company are valued at $101596545868.
This represents a growth rate of 5.437% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $30604882236, exhibiting a growth rate of 18.446% year-on-year.
The receivables, another significant portion of the current assets, are valued at $24454543644.
The year-on-year growth rate for receivables is -3.375%.
The inventory, which forms a critical part of the assets, is valued at $44152171194.
This represents a healthy year-on-year growth of 10.846%
On the liabilities side, the company's current liabilities total $49975202561.
This reflects a growth rate of -22.297% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
30604.88
25838.58
50263.47
20322.82
26846.23
26966.55
Receavebles
24454.54
25308.77
22905.19
19848.39
21077.46
25516.02
Inventory
44152.17
39832.04
25225.28
23688.89
17015.98
15615.96
Other
2384.95
439.30
493.98
426.45
114.22
225.19
Total Current Assets
101596.55
96357.75
98887.92
64466.55
65053.89
68869.66
Acc Payable
10951.76
15840.53
8982.26
5286.76
6385.09
5056.81
Short Term Debt
25386.19
37424.96
10427.31
4978.16
23872.47
12366.20
Other Current Liab
12247.08
10366.12
0.00
0.00
0.00
0.00
Current Liabilities
49975.20
64315.53
30014.75
18398.70
42495.63
27787.57
Capital Structure
When examining the capital structure of Yuyu Pharma, Inc., it is clear that the company manages a robust portfolio.
The value of their total assets clocks in at $198213526767.
When juxtaposed with the previous year, this marks a growth rate of 1.541%, showcasing the company's ability to steadily grow its asset base.
Turning to liabilities, the company has total liabilities amounting to $77857871884.
Compared to the prior year, this reflects a growth rate of 8.390%.
The long-term debt forms a sizable part of these liabilities, coming in at $13640045400.
Over the last year, the long-term debt has grown by 636.741%.
On the asset side, the cash and equivalent reserves are worth $30604882236.
The year-on-year growth of these reserves is 18.446%.
The company's common stock, another important asset, holds a value of $17609191000, growing at a rate of 0.000% from the previous year.
Finally, the company's retained earnings stand at $13946494000, marking a growth rate of -55.579% year-over-year.
These earnings represent the profits that Yuyu Pharma, Inc. has chosen to reinvest in the business rather than distribute as dividends.
Total Assets
$198,213.53
Total liabilities
$77,857,871,884.00
Long term debt
$13,640.05
Cash and eqv
$30,604,882,236.00
Goodwill
$503.22
Retained earnings
$13,946,494,000.00
Common stock
$6,208.29
Enterprise Value
$2.55
Historical dividend key summary
Yuyu Pharma, Inc.'s dividend per share is $110, showing the earnings shared with shareholders per share. It has grown by 0.000% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.
Years
Q1
Q2
Q3
Q4
Total
2024
0.000
110.000
0.000
0.000
110.000
2023
0.000
110.000
0.000
0.000
110.000
2022
0.000
110.000
0.000
0.000
110.000
2021
0.000
110.000
0.000
0.000
110.000
2020
0.000
110.000
0.000
0.000
110.000
2019
0.000
105.000
0.000
0.000
105.000
2018
0.000
100.000
0.000
0.000
100.000
2017
0.000
0.000
95.000
0.000
95.000
2016
95.000
0.000
0.000
0.000
95.000
2015
95.000
0.000
0.000
0.000
95.000
2014
95.000
0.000
0.000
0.000
95.000
2013
85.000
0.000
0.000
0.000
85.000
2012
65.000
0.000
0.000
0.000
65.000
2011
55.000
0.000
0.000
0.000
55.000
2010
45.000
0.000
0.000
0.000
45.000
2009
40.000
0.000
0.000
0.000
40.000
2008
155.000
0.000
0.000
0.000
155.000
2007
125.000
0.000
0.000
0.000
125.000
2006
115.000
0.000
0.000
0.000
115.000
Net earnings per share (EPS)
Yuyu Pharma, Inc. has an EPS of $-420.48, which signifies the profit allocated per share of common stock. With a growth rate of -141.295% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
Years
Q1
Q2
Q3
Q4
Total
2023
28.02
-213.76
-167.6
-67.14
-420.48
2022
-1.8
-21.92
-40.79
-109.75
-174.26
2021
56.94
-16.52
-61.46
-55.6
-76.64
2020
226.04
-111.05
105.01
-52.08
167.92
2019
131.57
115.23
105.98
142.28
495.06
2018
192.46
90.26
48.7
90.03
421.45
2017
176.08
159.98
187.65
-
523.71
2016
6.02
38.02
225.68
167.47
437.19
2015
-820.68
-75.85
-32.93
57.6
-871.86
2014
123.13
-142.48
84.47
95.84
160.96
2013
262.12
12.35
33.99
27.26
335.72
2012
-
21.83
8.8
19.52
50.15
2011
116.08
42.97
91.85
88.91
339.81
2010
587.94
34.48
-204.51
171.07
588.98
2009
-488.97
-372.33
-120.88
143.61
-838.57
2008
45.69
127.51
110.47
-345.25
-61.58
2007
-
685.23
224.76
466.54
1376.53
Brief information
Yuyu Pharma, Inc. (000225.KS) stock split history
Understanding the historical stock splits of Yuyu Pharma, Inc. (000225.KS) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on March 30, 2021 with a ratio of 2:1. Throughout its history, the company has undergone 2 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.
